Using cohorts from 2 large observational studies, researchers investigated whether duration of diabetes and extent of weight loss may be a marker of risk for pancreatic cancer.
[Cancer Management and Research] Researchers present a comparison study on the sensitivity and accuracy of 3 types of imaging studies — contrast-enhanced ultrasound, MRI, and computed tomography — in diagnosing and classifying pancreatic cystic neoplasms.
The study results suggest that patients with weight loss after age 50 years in the context of new-onset type 2 diabetes may be good candidates for pancreatic cancer screening.
Area under the ROC curve estimated by cross-validation was 0.62 for multifactor model.
In the management of PNETs it is important to differentiate between functional and nonfunctional PNETs in order to determine the course of treatment.